|
BS, Jackson State University, 2006
presentations
Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80
Annual Biomedical Research Conference for Minority Students
Haile, S.T., Bosch, J.J., Agu, N.I., Zeender, A.M., Somasundaram, P., Srivastava, M.K., Britting, S., Wolf, J.B., Ksander, B.R., Ostrand-Rosengerg, S.
St. Louis, MO
November 12, 2011
Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80
American Association of Immunologists Annual Meeting
Haile, S.T., Bosch, J.J., Agu, N.I., Zeender, A.M., Somasundaram, P., Srivastava, M.K., Britting, S., Wolf, J.B., Ksander, B.R., Ostrand-Rosenberg, S.
San Francisco, CA
May 13, 2011
Cell Surface Expression of Programmed Death Ligand 1 is Prevented in Tumor Cells Co-Expressing CD80
American Association of Immunologists Annual Meeting
Haile, S.T. Bosch, J.J., Agu, N., Ostrand-Rosenberg, S.
Baltimore, MD
May 10, 2010
Cell Surface Expression of Programmed Death Ligand 1 is Prevented in Tumor Cells Co-Expressing CD80
American Association for Cancer Research Annual Meeting
Haile, S.T. Bosch, J.J., Agu, N., Ostrand-Rosenberg, S.
Washington, D.C.
April 21, 2010
Cell Surface Expression of Programmed Death Ligand 1 is Prevented in Tumor Cells Co-Expressing CD80
Keystone Symposia: Molecular and Cellular Biology of Immune Escape in Cancer
Haile, S.T. Bosch, J.J., Agu, N., Ostrand-Rosenberg, S.
Keystone, CO
February 9, 2010
Exploiting Uveal Melanoma Vaccines for the Therapy of Cutaneous Malignant Melanoma
Look Ahead XII Symposium
Haile, S.T. Bosch, J. Ostrand-Rosenberg, S.
Baltimore, MD
November 12, 2008
|
